Bottom line
Is DCCCX a good fund? The bottom line
DCCCX is the Class C share class of Nomura Small Cap Core Fund, an actively managed small-cap mutual fund from Voya.
Its expense ratio is 1.79% — about $179 a year on every $10,000 invested, more expensive than 91% of small-cap funds we track.
It returned +2.6% over one year, +5.3% a year over five years, +8.2% a year over ten (as of Dec 31, 2025, per its prospectus).
With $5.5 billion in net assets and 138 holdings, its largest position is Semtech Corp (4.0%) and the top 10 make up 19.8% of the portfolio.
What stands out
- No front-end sales load
What to watch
- Expensive for its category (1.79%)
- 12b-1 marketing fee of 1% a year
Updated Nov 19, 2026
What DCCCX invests in
Nomura Small Cap Core Fund seeks long-term capital appreciation.
The Fund invests primarily in stocks of small companies that its investment manager, Delaware Management Company (Manager), believes have a combination of attractive valuations, growth prospects, and strong cash flows. Under normal circumstances, at least 80% of the Funds net assets, plus the amount of any borrowings for investment purposes, will be in investments of small-capitalization companies (80% policy). The Fund considers small-capitalization companies to be companies within the market capitalization range of the Russell 2000 Index at the time of purchase. The Funds 80% policy is nonfundamental and may be changed without shareholder approval. Fund shareholders would be given at least 60 days notice prior to any such change.
From the fund's prospectus (filed Mar 27, 2026).
DCCCX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| DCCCX | +2.6% | +5.3% | +8.2% |
| Small-Cap median | +7.6% | +7.0% | +9.2% |
Source: Fund prospectus, as of Dec 31, 2025
What DCCCX costs
On a $10,000 investment, DCCCX's 1.79% expense ratio costs about $179 a year. The prospectus estimates $2,105 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.
DCCCX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Semtech Corp SMTC | 4.04% |
| 2 | Myr Group Inc MYRG | 2.02% |
| 3 | Modine Manufacturing Company MOD | 1.98% |
| 4 | Axsome Therapeutics Inc AXSM | 1.83% |
| 5 | Travere Therapeutics Inc TVTX | 1.78% |
| 6 | Credo Technology Group Holding Ltd CRDO | 1.76% |
| 7 | Silicon Laboratories Inc SLAB | 1.65% |
| 8 | Ligand Pharmaceuticals Inc LGND | 1.62% |
| 9 | Arcosa Inc ACA | 1.56% |
| 10 | Esco Technologies Inc ESE | 1.54% |
Source: SEC Form N-PORT, period ended May 29, 2026
The top 10 make up 19.8% of the fund. See all top 25 holdings and asset mix →